Downs Christopher

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$393,689.55
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Downs Christopher

According to the SEC Form 4 filings, Downs Christopher, being in a position of

  1. Chief Financial Officer at CNS Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 66666 shares for $20,000, and sold 0 shares,
    over all time since 2020-08-24, has bought 248266 shares for $363,670, and sold 0 shares.

The largest purchase of all time was on 2020-08-24 and amounted to 142000 shares of CNS Pharmaceuticals, Inc. for $289,680.

Biography of Downs Christopher

No biography is available at this moment.

2024-02-01PurchaseCNS Pharmaceuticals, Inc.
CNSP
Chief Financial Officer
66,666
1.2878%
$0.30$20,000-79.37%
2023-08-22PurchaseCNS Pharmaceuticals, Inc.
CNSP
Chief Financial Officer
27,000
0.4674%
$1.27$34,177-78.05%
2023-04-17PurchaseCNS Pharmaceuticals, Inc.
CNSP
Chief Financial Officer
3,100
0.1892%
$3.20$9,920-42%
2021-12-06PurchaseCNS Pharmaceuticals, Inc.
CNSP
Chief Financial Officer
5,000
0.0182%
$0.94$4,702-70.09%
2021-11-19PurchaseCNS Pharmaceuticals, Inc.
CNSP
Chief Financial Officer
4,500
0.0166%
$1.15$5,192-74.58%
2020-08-24PurchaseCNS Pharmaceuticals, Inc.
CNSP
Chief Financial Officer
142,000
0.8136%
$2.04$289,680-7.87%
2017-08-14PurchaseInfuSystem Holdings, Inc.
INFU
CFO (interim)
15,800
0.0677%
$1.90$30,020+21.03%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.